Skip to content

Editorial Policy

Last updated: October 19, 2026

Accuracy and sourcing

  • Vendor facts come from the vendor's own website and independent public sources, and every review shows the date the facts were last checked.
  • Scientific statements are based on peer-reviewed journals, ClinicalTrials.gov, U.S. government agencies (FDA, NIH, CDC) and official company disclosures.
  • We distinguish clearly between clinical-trial findings, regulatory status and vendor claims.

Health content standards

  • We always state that retatrutide is investigational and not FDA-approved.
  • We do not give dosing instructions or recommend human use of research chemicals.
  • Trial doses are reported only as they appear in published studies.

Independence and commercial relationships

Our business model relies on affiliate commissions, which can influence which vendors appear and in what order. Vendors cannot edit reviews, and we do not remove documented facts at a vendor's request. See the affiliate disclosure.

Use of AI tools

We use AI tools to help monitor news, draft summaries and check consistency. Weekly news articles are drafted with AI assistance from sources found at publication time, and every article links to the sources it relies on. If you find an error, tell us and we will correct it.

External links

We link to sources so readers can verify our claims. Most outbound links carry a nofollow attribute; links to vendors are markedsponsored.

Corrections

Email contact@retarate.com with the page URL and the correction. Substantive corrections are noted with an updated date on the page.